Keywords: forest, labs, sales, hit, celexa, competition, drugmaker

Forest Labs' sales hit by Celexa competition

Article | 25 April 2005

Print This

US drugmaker Forest Laboratories suffered a sales setback in the first quarter of 2005 as a result of generic competition for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in